Aurora Cannabis (ACB) expands with $26.5M Safari Flower acquisition

Rhea-AI Filing Summary

Aurora Cannabis Inc. reported that a wholly owned subsidiary, Aurora Sub, has indirectly purchased 100% of the shares of 9869247 Canada Limited (Safari Flower Company), an established EU GMP certified cannabis cultivator and manufacturer.

The aggregate consideration for the Safari Flower Company transaction is valued at $26.5 million, which includes a $2 million cash payment that is contingent on certain conditions. At closing, Aurora issued the selling shareholder 2,417,180 common shares and paid $15 million in cash, with amounts subject to customary post-closing adjustments.

Insights

Equity analyst – cannabis sector M&A

Aurora adds an EU GMP cultivator via a $26.5M cash-and-share deal.

Aurora Cannabis, through a wholly owned subsidiary, acquired all shares of Safari Flower Company, an EU GMP certified cannabis cultivator and manufacturer, for aggregate consideration of $26.5 million. Payment combines cash and Aurora common shares, with a portion contingent on conditions.

The structure includes $15 million cash at closing, issuance of 2,417,180 common shares, and a further $2 million cash component that depends on satisfying specified conditions. Customary post-closing adjustments apply, which can slightly change the final consideration.

This move adds an established EU GMP platform, which is important for medical and export markets, but the filing does not quantify Safari Flower Company’s revenues or profitability. Future disclosures in company filings may provide more detail on integration progress and financial contribution.

Key Figures

Aggregate consideration: $26.5 million Cash at closing: $15 million Contingent cash payment: $2 million +3 more

6 metrics

Aggregate consideration $26.5 million Total value of Safari Flower Company transaction

Cash at closing $15 million Cash portion paid to selling shareholder at closing

Contingent cash payment $2 million Cash payment contingent on satisfaction of conditions

Shares issued 2,417,180 common shares Aurora common shares issued as part of consideration

Date of material change April 14, 2026 Effective date of Safari Flower Company acquisition

Date of report April 16, 2026 Date the material change report was signed

Key Terms

Material Change Report, EU GMP certified, aggregate consideration, contingent on satisfaction of certain conditions, +1 more

5 terms

Material Change Report regulatory

"Exhibit 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT"

A material change report is a public notice that a company must file and share whenever new information or an event is significant enough to likely influence an investor’s decision. Think of it like an urgent update board that tells shareholders about big shifts—such as major deals, leadership changes, sudden losses, or legal issues—so investors can reassess risk and value with the same facts everyone else has.

EU GMP certified technical

"an established EU GMP certified cannabis cultivator and manufacturer"

aggregate consideration financial

"Aggregate consideration is valued at $26.5 million"

contingent on satisfaction of certain conditions financial

"inclusive of a cash payment of $2 million that is contingent on satisfaction of certain conditions"

National Instrument 51-102 regulatory

"Reliance on subsection 7.1(2) of National Instrument 51-102"

National Instrument 51-102 is a Canadian securities rule that requires public companies to regularly publish clear, standardized information about their finances and significant developments, such as quarterly and annual reports, management discussion and analysis, and notices of material changes. For investors it acts like a rule forcing businesses to keep their financial “windows” clear and up to date, making it easier to compare companies, spot risks, and make informed decisions.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2026

Commission File No. 001-38691

AURORA CANNABIS INC. (Translation of registrant's name into English)

2207 90B St. SW
Edmonton, Alberta T6X 1V8
Canada
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F  ☐ Form 40-F  ☒

INCORPORATION BY REFERENCE

This Form 6-K is hereby filed and incorporated by reference in the registrant’s Registration Statements on Form F-10 (File No. 333-284958) and on Form S-8 (File No. 333-282253).

SUBMITTED HEREWITH

Exhibits		Description
99.1		Material Change Report dated April 16, 2026

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AURORA CANNABIS INC.

/s/ Miguel Martin

Miguel Martin
Chief Executive Officer

Date: April 16, 2026

Exhibit 99.1 

FORM 51-102F3

MATERIAL CHANGE REPORT

Item 1 Name and Address of Company

Aurora Cannabis Inc. (“Aurora” or the “Company”)

2207-90b Street SW

Edmonton, Alberta

T6X 1V8

Item 2 Date of Material Change

April 14, 2026

Item 3 News Release

A press release describing the material change was disseminated by Aurora on April 15, 2026 through Cision PR Newswire and can be found on SEDAR+ at www.sedarplus.ca.

Item 4 Summary of Material Change

A wholly owned subsidiary of Aurora (“Aurora Sub”) indirectly purchased 100% of the shares of 9869247 Canada Limited (“Safari Flower Company”), an established EU GMP certified cannabis cultivator and manufacturer. Aggregate consideration is valued at $26.5 million, subject to customary adjustments, and inclusive of a cash payment of $2 million that is contingent on satisfaction of certain conditions (the “Transaction”).

Item 5 Full Description of Material Change

5.1        Full Description of Material Change

On April 14, 2026, Aurora Sub indirectly purchased 100% of the shares of Safari Flower Company for aggregate consideration valued at $26.5 million, inclusive of a cash payment of $2 million that is contingent on satisfaction of certain conditions. As consideration on closing, Aurora (i) issued the selling shareholder 2,417,180 common shares; and (ii) paid the selling shareholder $15 million in cash, subject to customary adjustments post closing.

5.2        Disclosure for Restructuring Transactions

Not applicable.

Item 6 Reliance on subsection 7.1(2) of National Instrument 51-102

Not applicable.

Item 7 Omitted Information

Not applicable.

 - 2 -

Item 8 Executive Officer

Further information regarding the matters described in this report may be obtained from Nathalie Clark, Executive Vice President, General Counsel & Corporate Secretary who is knowledgeable about the details of the Transaction and may be contacted at nathalie.clark@auroramj.com.

Item 9 Date of Report

April 16, 2026.

FAQ

What transaction did Aurora Cannabis (ACB) disclose in this Form 6-K?

Aurora Cannabis disclosed that a wholly owned subsidiary acquired 100% of the shares of 9869247 Canada Limited, known as Safari Flower Company, an EU GMP certified cannabis cultivator and manufacturer, in a cash-and-share transaction described as a material change.

How much is Aurora Cannabis (ACB) paying for Safari Flower Company?

Aurora is paying aggregate consideration valued at $26.5 million for Safari Flower Company. This total includes $15 million in cash at closing, 2,417,180 Aurora common shares issued to the seller, and a further $2 million cash payment contingent on certain conditions.

What is the cash and share breakdown of Aurora Cannabis’s Safari Flower acquisition?

At closing, Aurora paid the selling shareholder $15 million in cash and issued 2,417,180 common shares. The overall $26.5 million consideration also includes a $2 million cash payment that will be made only if specified conditions are satisfied, plus customary post-closing adjustments.

Why is Safari Flower Company significant for Aurora Cannabis (ACB)?

Safari Flower Company is described as an established EU GMP certified cannabis cultivator and manufacturer. EU GMP certification is important for supplying certain medical and international markets, so acquiring Safari Flower Company adds a compliant cultivation and manufacturing platform to Aurora’s portfolio.

When did the Aurora Cannabis (ACB) Safari Flower transaction occur?

The material change date for the Safari Flower transaction is April 14, 2026. Aurora reported that its wholly owned subsidiary completed the indirect purchase of 100% of Safari Flower Company’s shares on that date and subsequently issued a related press release on April 15, 2026.

Who can investors contact at Aurora Cannabis (ACB) for more information on the transaction?

Aurora indicates that further information can be obtained from Nathalie Clark, Executive Vice President, General Counsel & Corporate Secretary. She is identified as knowledgeable about the details of the transaction and can be contacted at the email address provided in the report.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-991 MATERIAL CHANGE REPORT 8.0 KB